Purification and structure of human liver aspartylglucosaminidase

We have recently diagnosed aspartylglucosaminuria (AGU) in four members of a Canadian family. AGU is a lysosomal storage disease in which asparagine-linked glycopeptides accumulate to particularly high concentrations in liver, spleen and thyroid of affected individuals. A lesser accumulation of thes...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical journal 1992-12, Vol.288 (3), p.1005-1010
Hauptverfasser: RIP, J. W, COULTER-MACKIE, M. B, RUPAR, C. A, GORDON, B. A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1010
container_issue 3
container_start_page 1005
container_title Biochemical journal
container_volume 288
creator RIP, J. W
COULTER-MACKIE, M. B
RUPAR, C. A
GORDON, B. A
description We have recently diagnosed aspartylglucosaminuria (AGU) in four members of a Canadian family. AGU is a lysosomal storage disease in which asparagine-linked glycopeptides accumulate to particularly high concentrations in liver, spleen and thyroid of affected individuals. A lesser accumulation of these glycopeptides is seen in the kidney and brain, and they are also excreted in the urine. The altered metabolism in AGU results from a deficiency of the enzyme aspartylglucosaminidase (1-aspartamido-beta-N-acetylglucosamine amidohydrolase), which hydrolyses the asparagine to N-acetylglucosamine linkages of glycoproteins and glycopeptides. We have used human liver as a source of material for the purification of aspartylglucosaminidase. The enzyme has been purified to homogeneity by using heat treatment, (NH4)2SO4 fractionation, and chromatography on concanavalin A-Sepharose, DEAE-Sepharose, sulphopropyl-Sephadex, hydroxyapatite, DEAE-cellulose and Sephadex G-100. Enzyme activity was followed by measuring colorimetrically the N-acetylglucosamine released from aspartylglucosamine at 56 degrees C. The purified enzyme protein ran at a 'native' molecular mass of 56 kDa in SDS/12.5%-PAGE gels, and the enzyme activity could be quantitatively recovered at this molecular mass by using gel slices as enzyme source in the assay. After denaturation by boiling in SDS the 56 kDa protein was lost with the corresponding appearance of polypeptides alpha,beta and beta 1, lacking enzyme activity, at 24.6, 18.4 and 17.4 kDa respectively. Treatment of heat-denatured enzyme with N-glycosidase F resulted in the following decreases in molecular mass; 24.6 to 23 kDa and 18.4 and 17.4 to 15.8 kDa. These studies indicate that human liver aspartylglucosaminidase is composed of two non-identical polypeptides, each of which is glycosylated. The N-termini of alpha,beta and beta 1 were directly accessible for sequencing, and the first 21, 26 and 22 amino acids respectively were identified.
doi_str_mv 10.1042/bj2881005
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1131987</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73459467</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-7683a522a14fe4cd1d5b221726a817e368afb5cda6271ce056d3b2295d7096733</originalsourceid><addsrcrecordid>eNpVkEtLAzEUhYMotVYX_gBhFiK4GM1NMklmI5TiCwq60HW4zWTayDxqMlPov7elperqLs7Hdy6HkEugd0AFu599Ma2B0uyIDEEommrF9DEZUiZFKimDU3IW4xelIKigAzIApiFXakjG733wpbfY-bZJsCmS2IXedn1wSVsmi77GJqn8yoUE4xJDt67mVW_biLVvfIHRnZOTEqvoLvZ3RD6fHj8mL-n07fl1Mp6mlud5lyqpOWaMIYjSCVtAkc0YA8UkalCOS43lLLMFSqbAOprJgm-APCsUzaXifEQedt5lP6tdYV3TBazMMvgaw9q06M3_pPELM29XBoBDrtVGcLMXhPa7d7EztY_WVRU2ru2jUVxkuZBb8HYH2tDGGFx5KAFqtnubw94b9urvV7_kbuBNfr3PMVqsyoCN9fGACSGUYoL_AL7SiL0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73459467</pqid></control><display><type>article</type><title>Purification and structure of human liver aspartylglucosaminidase</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>RIP, J. W ; COULTER-MACKIE, M. B ; RUPAR, C. A ; GORDON, B. A</creator><creatorcontrib>RIP, J. W ; COULTER-MACKIE, M. B ; RUPAR, C. A ; GORDON, B. A</creatorcontrib><description>We have recently diagnosed aspartylglucosaminuria (AGU) in four members of a Canadian family. AGU is a lysosomal storage disease in which asparagine-linked glycopeptides accumulate to particularly high concentrations in liver, spleen and thyroid of affected individuals. A lesser accumulation of these glycopeptides is seen in the kidney and brain, and they are also excreted in the urine. The altered metabolism in AGU results from a deficiency of the enzyme aspartylglucosaminidase (1-aspartamido-beta-N-acetylglucosamine amidohydrolase), which hydrolyses the asparagine to N-acetylglucosamine linkages of glycoproteins and glycopeptides. We have used human liver as a source of material for the purification of aspartylglucosaminidase. The enzyme has been purified to homogeneity by using heat treatment, (NH4)2SO4 fractionation, and chromatography on concanavalin A-Sepharose, DEAE-Sepharose, sulphopropyl-Sephadex, hydroxyapatite, DEAE-cellulose and Sephadex G-100. Enzyme activity was followed by measuring colorimetrically the N-acetylglucosamine released from aspartylglucosamine at 56 degrees C. The purified enzyme protein ran at a 'native' molecular mass of 56 kDa in SDS/12.5%-PAGE gels, and the enzyme activity could be quantitatively recovered at this molecular mass by using gel slices as enzyme source in the assay. After denaturation by boiling in SDS the 56 kDa protein was lost with the corresponding appearance of polypeptides alpha,beta and beta 1, lacking enzyme activity, at 24.6, 18.4 and 17.4 kDa respectively. Treatment of heat-denatured enzyme with N-glycosidase F resulted in the following decreases in molecular mass; 24.6 to 23 kDa and 18.4 and 17.4 to 15.8 kDa. These studies indicate that human liver aspartylglucosaminidase is composed of two non-identical polypeptides, each of which is glycosylated. The N-termini of alpha,beta and beta 1 were directly accessible for sequencing, and the first 21, 26 and 22 amino acids respectively were identified.</description><identifier>ISSN: 0264-6021</identifier><identifier>EISSN: 1470-8728</identifier><identifier>DOI: 10.1042/bj2881005</identifier><identifier>PMID: 1281977</identifier><language>eng</language><publisher>Colchester: Portland Press</publisher><subject>Amino Acid Sequence ; Analytical, structural and metabolic biochemistry ; Aspartylglucosylaminase - chemistry ; Aspartylglucosylaminase - isolation &amp; purification ; Aspartylglucosylaminase - metabolism ; Biological and medical sciences ; Dextrans ; Electrophoresis, Polyacrylamide Gel ; Enzymes and enzyme inhibitors ; Ethanolamines ; Fundamental and applied biological sciences. Psychology ; Glycoside Hydrolases - metabolism ; Humans ; Hydrolases ; Hydrolases - isolation &amp; purification ; Liver - enzymology ; Macromolecular Substances ; Molecular Sequence Data ; Sepharose ; Sodium Dodecyl Sulfate</subject><ispartof>Biochemical journal, 1992-12, Vol.288 (3), p.1005-1010</ispartof><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-7683a522a14fe4cd1d5b221726a817e368afb5cda6271ce056d3b2295d7096733</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1131987/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1131987/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4447724$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1281977$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>RIP, J. W</creatorcontrib><creatorcontrib>COULTER-MACKIE, M. B</creatorcontrib><creatorcontrib>RUPAR, C. A</creatorcontrib><creatorcontrib>GORDON, B. A</creatorcontrib><title>Purification and structure of human liver aspartylglucosaminidase</title><title>Biochemical journal</title><addtitle>Biochem J</addtitle><description>We have recently diagnosed aspartylglucosaminuria (AGU) in four members of a Canadian family. AGU is a lysosomal storage disease in which asparagine-linked glycopeptides accumulate to particularly high concentrations in liver, spleen and thyroid of affected individuals. A lesser accumulation of these glycopeptides is seen in the kidney and brain, and they are also excreted in the urine. The altered metabolism in AGU results from a deficiency of the enzyme aspartylglucosaminidase (1-aspartamido-beta-N-acetylglucosamine amidohydrolase), which hydrolyses the asparagine to N-acetylglucosamine linkages of glycoproteins and glycopeptides. We have used human liver as a source of material for the purification of aspartylglucosaminidase. The enzyme has been purified to homogeneity by using heat treatment, (NH4)2SO4 fractionation, and chromatography on concanavalin A-Sepharose, DEAE-Sepharose, sulphopropyl-Sephadex, hydroxyapatite, DEAE-cellulose and Sephadex G-100. Enzyme activity was followed by measuring colorimetrically the N-acetylglucosamine released from aspartylglucosamine at 56 degrees C. The purified enzyme protein ran at a 'native' molecular mass of 56 kDa in SDS/12.5%-PAGE gels, and the enzyme activity could be quantitatively recovered at this molecular mass by using gel slices as enzyme source in the assay. After denaturation by boiling in SDS the 56 kDa protein was lost with the corresponding appearance of polypeptides alpha,beta and beta 1, lacking enzyme activity, at 24.6, 18.4 and 17.4 kDa respectively. Treatment of heat-denatured enzyme with N-glycosidase F resulted in the following decreases in molecular mass; 24.6 to 23 kDa and 18.4 and 17.4 to 15.8 kDa. These studies indicate that human liver aspartylglucosaminidase is composed of two non-identical polypeptides, each of which is glycosylated. The N-termini of alpha,beta and beta 1 were directly accessible for sequencing, and the first 21, 26 and 22 amino acids respectively were identified.</description><subject>Amino Acid Sequence</subject><subject>Analytical, structural and metabolic biochemistry</subject><subject>Aspartylglucosylaminase - chemistry</subject><subject>Aspartylglucosylaminase - isolation &amp; purification</subject><subject>Aspartylglucosylaminase - metabolism</subject><subject>Biological and medical sciences</subject><subject>Dextrans</subject><subject>Electrophoresis, Polyacrylamide Gel</subject><subject>Enzymes and enzyme inhibitors</subject><subject>Ethanolamines</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Glycoside Hydrolases - metabolism</subject><subject>Humans</subject><subject>Hydrolases</subject><subject>Hydrolases - isolation &amp; purification</subject><subject>Liver - enzymology</subject><subject>Macromolecular Substances</subject><subject>Molecular Sequence Data</subject><subject>Sepharose</subject><subject>Sodium Dodecyl Sulfate</subject><issn>0264-6021</issn><issn>1470-8728</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkEtLAzEUhYMotVYX_gBhFiK4GM1NMklmI5TiCwq60HW4zWTayDxqMlPov7elperqLs7Hdy6HkEugd0AFu599Ma2B0uyIDEEommrF9DEZUiZFKimDU3IW4xelIKigAzIApiFXakjG733wpbfY-bZJsCmS2IXedn1wSVsmi77GJqn8yoUE4xJDt67mVW_biLVvfIHRnZOTEqvoLvZ3RD6fHj8mL-n07fl1Mp6mlud5lyqpOWaMIYjSCVtAkc0YA8UkalCOS43lLLMFSqbAOprJgm-APCsUzaXifEQedt5lP6tdYV3TBazMMvgaw9q06M3_pPELM29XBoBDrtVGcLMXhPa7d7EztY_WVRU2ru2jUVxkuZBb8HYH2tDGGFx5KAFqtnubw94b9urvV7_kbuBNfr3PMVqsyoCN9fGACSGUYoL_AL7SiL0</recordid><startdate>19921215</startdate><enddate>19921215</enddate><creator>RIP, J. W</creator><creator>COULTER-MACKIE, M. B</creator><creator>RUPAR, C. A</creator><creator>GORDON, B. A</creator><general>Portland Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19921215</creationdate><title>Purification and structure of human liver aspartylglucosaminidase</title><author>RIP, J. W ; COULTER-MACKIE, M. B ; RUPAR, C. A ; GORDON, B. A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-7683a522a14fe4cd1d5b221726a817e368afb5cda6271ce056d3b2295d7096733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Amino Acid Sequence</topic><topic>Analytical, structural and metabolic biochemistry</topic><topic>Aspartylglucosylaminase - chemistry</topic><topic>Aspartylglucosylaminase - isolation &amp; purification</topic><topic>Aspartylglucosylaminase - metabolism</topic><topic>Biological and medical sciences</topic><topic>Dextrans</topic><topic>Electrophoresis, Polyacrylamide Gel</topic><topic>Enzymes and enzyme inhibitors</topic><topic>Ethanolamines</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Glycoside Hydrolases - metabolism</topic><topic>Humans</topic><topic>Hydrolases</topic><topic>Hydrolases - isolation &amp; purification</topic><topic>Liver - enzymology</topic><topic>Macromolecular Substances</topic><topic>Molecular Sequence Data</topic><topic>Sepharose</topic><topic>Sodium Dodecyl Sulfate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>RIP, J. W</creatorcontrib><creatorcontrib>COULTER-MACKIE, M. B</creatorcontrib><creatorcontrib>RUPAR, C. A</creatorcontrib><creatorcontrib>GORDON, B. A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Biochemical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>RIP, J. W</au><au>COULTER-MACKIE, M. B</au><au>RUPAR, C. A</au><au>GORDON, B. A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Purification and structure of human liver aspartylglucosaminidase</atitle><jtitle>Biochemical journal</jtitle><addtitle>Biochem J</addtitle><date>1992-12-15</date><risdate>1992</risdate><volume>288</volume><issue>3</issue><spage>1005</spage><epage>1010</epage><pages>1005-1010</pages><issn>0264-6021</issn><eissn>1470-8728</eissn><abstract>We have recently diagnosed aspartylglucosaminuria (AGU) in four members of a Canadian family. AGU is a lysosomal storage disease in which asparagine-linked glycopeptides accumulate to particularly high concentrations in liver, spleen and thyroid of affected individuals. A lesser accumulation of these glycopeptides is seen in the kidney and brain, and they are also excreted in the urine. The altered metabolism in AGU results from a deficiency of the enzyme aspartylglucosaminidase (1-aspartamido-beta-N-acetylglucosamine amidohydrolase), which hydrolyses the asparagine to N-acetylglucosamine linkages of glycoproteins and glycopeptides. We have used human liver as a source of material for the purification of aspartylglucosaminidase. The enzyme has been purified to homogeneity by using heat treatment, (NH4)2SO4 fractionation, and chromatography on concanavalin A-Sepharose, DEAE-Sepharose, sulphopropyl-Sephadex, hydroxyapatite, DEAE-cellulose and Sephadex G-100. Enzyme activity was followed by measuring colorimetrically the N-acetylglucosamine released from aspartylglucosamine at 56 degrees C. The purified enzyme protein ran at a 'native' molecular mass of 56 kDa in SDS/12.5%-PAGE gels, and the enzyme activity could be quantitatively recovered at this molecular mass by using gel slices as enzyme source in the assay. After denaturation by boiling in SDS the 56 kDa protein was lost with the corresponding appearance of polypeptides alpha,beta and beta 1, lacking enzyme activity, at 24.6, 18.4 and 17.4 kDa respectively. Treatment of heat-denatured enzyme with N-glycosidase F resulted in the following decreases in molecular mass; 24.6 to 23 kDa and 18.4 and 17.4 to 15.8 kDa. These studies indicate that human liver aspartylglucosaminidase is composed of two non-identical polypeptides, each of which is glycosylated. The N-termini of alpha,beta and beta 1 were directly accessible for sequencing, and the first 21, 26 and 22 amino acids respectively were identified.</abstract><cop>Colchester</cop><pub>Portland Press</pub><pmid>1281977</pmid><doi>10.1042/bj2881005</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0264-6021
ispartof Biochemical journal, 1992-12, Vol.288 (3), p.1005-1010
issn 0264-6021
1470-8728
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1131987
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Amino Acid Sequence
Analytical, structural and metabolic biochemistry
Aspartylglucosylaminase - chemistry
Aspartylglucosylaminase - isolation & purification
Aspartylglucosylaminase - metabolism
Biological and medical sciences
Dextrans
Electrophoresis, Polyacrylamide Gel
Enzymes and enzyme inhibitors
Ethanolamines
Fundamental and applied biological sciences. Psychology
Glycoside Hydrolases - metabolism
Humans
Hydrolases
Hydrolases - isolation & purification
Liver - enzymology
Macromolecular Substances
Molecular Sequence Data
Sepharose
Sodium Dodecyl Sulfate
title Purification and structure of human liver aspartylglucosaminidase
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T01%3A37%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Purification%20and%20structure%20of%20human%20liver%20aspartylglucosaminidase&rft.jtitle=Biochemical%20journal&rft.au=RIP,%20J.%20W&rft.date=1992-12-15&rft.volume=288&rft.issue=3&rft.spage=1005&rft.epage=1010&rft.pages=1005-1010&rft.issn=0264-6021&rft.eissn=1470-8728&rft_id=info:doi/10.1042/bj2881005&rft_dat=%3Cproquest_pubme%3E73459467%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73459467&rft_id=info:pmid/1281977&rfr_iscdi=true